Vialwirebiotech, curated
October 1, 2026, 2:13 PM
July 21, 2026
- 12:00 PM · BioWorld12:00 PMAgios’ phase II tebapivat splats in SCD, Pyrukynd top of mind — BioWorld
- 12:00 PM · BioWorld12:00 PMUS-based Axiom plans Hong Kong listing — BioWorld
- 11:45 AM · BioPharma Dive11:45 AMNovo sues Lilly, alleging ‘misleading’ advertising of obesity drugs — BioPharma Dive
- 11:00 AM · BioWorld11:00 AMAsia deal flurry draws AZ, Spero to $1B+ Dizal, Innovent assets — BioWorld
- 11:00 AM · BioWorld11:00 AMHansoh takes newco route to globalize IL-23 asset — BioWorld
- 11:00 AM · BioWorld11:00 AMAdvancell raises $315M to power global isotope strategy — BioWorld
- 10:53 AM · BioPharma Dive10:53 AMNovartis climbs on upbeat drug sales as key readouts loom — BioPharma Dive
- 10:15 AM · Nikkei Asia10:15 AMIndia approves its first dengue vaccine, from Japan's Takeda — Nikkei Asia
- 10:10 AM · Pharmaceutical Executive10:10 AM<![CDATA[FDA Grants Emergency Use Authorization for Seegene’s Multiplex PCR Assay ]]> — Pharmaceutical Executive
- 9:37 AM · STAT News
- 9:00 AM · BioWorld9:00 AMBreezebio and Ligachem partner on cancer vaccine research — BioWorld
- 9:00 AM · BioWorld9:00 AMAkari and Whitehawk collaborate on ADC research — BioWorld
- 9:00 AM · Labiotech (EU)9:00 AMRoche’s new gene sequencer on the market: where do current players stand? — Labiotech (EU)
- 8:38 AM · Drug Discovery World8:38 AMNew drug could change post-progression treatment of EGFR-NSCLC — Drug Discovery World
- 6:12 AM · Pharmaceutical Technology6:12 AMBristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory — Pharmaceutical Technology
- 5:08 AM · Pharmaceutical Technology5:08 AMEMA’s CHMP grants PRIME status to AbelZeta’s C-CAR168 — Pharmaceutical Technology
- 5:04 AM · Drug Discovery World5:04 AMAllogeneic CAR-T achieves durable remissions in metastatic solid tumours — Drug Discovery World
- 4:31 AM · Pharmaceutical Technology4:31 AMHalozyme and Incyte sign licence agreement for INCA033989 formulations — Pharmaceutical Technology
- 4:30 AM · STAT News
- 12:00 AM · FT — Pharmaceuticals12:00 AMInvestors bet on AI drug discovery despite approval gap — FT — Pharmaceuticals
July 20, 2026
- 7:39 PM · TechCrunch
- 2:38 PM · BioPharma Dive2:38 PMTempus to acquire cancer test maker Personalis for $1.5B — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMImmix investors skittish over exec's sexual assault arrest — BioWorld
- 12:00 PM · BioWorld12:00 PMRinascera launches with two rare genetic skin disease therapies — BioWorld
- 11:57 AM · BioPharma Dive11:57 AMPain drugmaker Latigo outlines plans to go public — BioPharma Dive
- 11:38 AM · Pharmaceutical Technology11:38 AMWhat Ojemda’s JCA reveals about new era of clinical HTA in Europe — Pharmaceutical Technology
- 10:18 AM · Pharmaceutical Executive10:18 AM<![CDATA[FDA Clears Consano’s IND for C-1101 ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMVeraxa Biotech receives feedback on BiTAC-TCE program — BioWorld
- 9:00 AM · BioWorld9:00 AMFunding to expand Sightera Biosciences’ AI-discovered programs — BioWorld
- 9:00 AM · BioWorld9:00 AMGan & Lee Pharmaceuticals synthesizes new CK1α molecular glue degraders — BioWorld
- 8:41 AM · Drug Discovery World8:41 AMPhase II triple-negative breast cancer trial restarts — Drug Discovery World
- 7:00 AM · SCMP — Tech7:00 AM‘Systemic leap’: China’s drug innovation push yields bumper crop — SCMP — Tech
- 6:59 AM · STAT News
- 6:46 AM · Pharmaceutical Technology6:46 AMNovartis and Takeda drugs gain rare blood cancer routine use on NHS — Pharmaceutical Technology
- 6:07 AM · Pharmaceutical Technology6:07 AMSamsung Biologics to acquire PolyPeptide in $1.81bn cash deal — Pharmaceutical Technology
- 4:45 AM · Drug Discovery World4:45 AMEpilepsyGTx partners with ClearPoint for gene therapy delivery — Drug Discovery World
- 12:00 AM · FT — Pharmaceuticals12:00 AMAstraZeneca highlights rare diseases in $80bn revenue push — FT — Pharmaceuticals